• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无碱基枢轴替换利用RNA干扰的靶向特异性。

Abasic pivot substitution harnesses target specificity of RNA interference.

作者信息

Lee Hye-Sook, Seok Heeyoung, Lee Dong Ha, Ham Juyoung, Lee Wooje, Youm Emilia Moonkyung, Yoo Jin Seon, Lee Yong-Seung, Jang Eun-Sook, Chi Sung Wook

机构信息

Division of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea.

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul 135-710, Korea.

出版信息

Nat Commun. 2015 Dec 18;6:10154. doi: 10.1038/ncomms10154.

DOI:10.1038/ncomms10154
PMID:26679372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4703836/
Abstract

Gene silencing via RNA interference inadvertently represses hundreds of off-target transcripts. Because small interfering RNAs (siRNAs) can function as microRNAs, avoiding miRNA-like off-target repression is a major challenge. Functional miRNA-target interactions are known to pre-require transitional nucleation, base pairs from position 2 to the pivot (position 6). Here, by substituting nucleotide in pivot with abasic spacers, which prevent base pairing and alleviate steric hindrance, we eliminate miRNA-like off-target repression while preserving on-target activity at ∼ 80-100%. Specifically, miR-124 containing dSpacer pivot substitution (6pi) loses seed-mediated transcriptome-wide target interactions, repression activity and biological function, whereas other conventional modifications are ineffective. Application of 6pi allows PCSK9 siRNA to efficiently lower plasma cholesterol concentration in vivo, and abolish potentially deleterious off-target phenotypes. The smallest spacer, C3, also shows the same improvement in target specificity. Abasic pivot substitution serves as a general means to harness the specificity of siRNA experiments and therapeutic applications.

摘要

通过RNA干扰实现的基因沉默会意外地抑制数百种脱靶转录本。由于小干扰RNA(siRNA)可以发挥微小RNA(miRNA)的功能,避免类似miRNA的脱靶抑制是一项重大挑战。已知功能性miRNA-靶标相互作用预先需要过渡成核,即从第2位到枢轴位置(第6位)的碱基对。在这里,我们通过用无碱基间隔物取代枢轴位置的核苷酸,这种间隔物可防止碱基配对并减轻空间位阻,从而消除了类似miRNA的脱靶抑制,同时保持了约80%-100%的靶向活性。具体而言,含有dSpacer枢轴取代(6pi)的miR-124失去了种子介导的全转录组范围的靶标相互作用、抑制活性和生物学功能,而其他常规修饰则无效。应用6pi可使PCSK9 siRNA在体内有效降低血浆胆固醇浓度,并消除潜在有害的脱靶表型。最小的间隔物C3在靶标特异性方面也表现出相同的改善。无碱基枢轴取代是一种利用siRNA实验和治疗应用特异性的通用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/cfe16d38d373/ncomms10154-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/18f5eaff5a9f/ncomms10154-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/15d73d2eb52c/ncomms10154-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/8d1383771217/ncomms10154-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/3970acf82ff3/ncomms10154-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/166a6e64fc9f/ncomms10154-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/3bcd6a137b09/ncomms10154-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/c57ff823e13f/ncomms10154-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/cfe16d38d373/ncomms10154-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/18f5eaff5a9f/ncomms10154-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/15d73d2eb52c/ncomms10154-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/8d1383771217/ncomms10154-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/3970acf82ff3/ncomms10154-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/166a6e64fc9f/ncomms10154-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/3bcd6a137b09/ncomms10154-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/c57ff823e13f/ncomms10154-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6f/4703836/cfe16d38d373/ncomms10154-f8.jpg

相似文献

1
Abasic pivot substitution harnesses target specificity of RNA interference.无碱基枢轴替换利用RNA干扰的靶向特异性。
Nat Commun. 2015 Dec 18;6:10154. doi: 10.1038/ncomms10154.
2
Rationally designed siRNAs without miRNA-like off-target repression.经过合理设计的小干扰RNA,不存在类似微小RNA的脱靶抑制效应。
BMB Rep. 2016 Mar;49(3):135-6. doi: 10.5483/bmbrep.2016.49.3.019.
3
Evaluation and control of miRNA-like off-target repression for RNA interference.miRNA 样非靶位抑制的评估与控制用于 RNA 干扰。
Cell Mol Life Sci. 2018 Mar;75(5):797-814. doi: 10.1007/s00018-017-2656-0. Epub 2017 Sep 13.
4
siAbasic: a comprehensive database for potent siRNA-6Ø sequences without off-target effects.siAbasic:一个没有脱靶效应的强效 siRNA-6Ø 序列的综合数据库。
Database (Oxford). 2018 Jan 1;2018:bay109. doi: 10.1093/database/bay109.
5
miRNA-target chimeras reveal miRNA 3'-end pairing as a major determinant of Argonaute target specificity.微小RNA-靶标嵌合体揭示微小RNA 3'端配对是AGO蛋白靶标特异性的主要决定因素。
Nat Commun. 2015 Nov 25;6:8864. doi: 10.1038/ncomms9864.
6
AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity.基于 AGO CLIP 的 SARS-CoV-2 强效 siRNA 序列的推测,具有抗纤维化 miRNA 样活性。
Sci Rep. 2021 Sep 27;11(1):19161. doi: 10.1038/s41598-021-98708-z.
7
The siRNA Non-seed Region and Its Target Sequences Are Auxiliary Determinants of Off-Target Effects.小干扰RNA的非种子区域及其靶序列是脱靶效应的辅助决定因素。
PLoS Comput Biol. 2015 Dec 11;11(12):e1004656. doi: 10.1371/journal.pcbi.1004656. eCollection 2015 Dec.
8
siRNA design principles and off-target effects.小干扰RNA的设计原则与脱靶效应。
Methods Mol Biol. 2013;986:59-71. doi: 10.1007/978-1-62703-311-4_4.
9
Guide Strand 3'-End Modifications Regulate siRNA Specificity.引导链3'端修饰调控小干扰RNA的特异性。
Chembiochem. 2016 Dec 14;17(24):2340-2345. doi: 10.1002/cbic.201600453. Epub 2016 Nov 7.
10
Structure-Guided Control of siRNA Off-Target Effects.结构导向的 siRNA 脱靶效应控制。
J Am Chem Soc. 2016 Jul 20;138(28):8667-9. doi: 10.1021/jacs.6b06137. Epub 2016 Jul 12.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
Single alkyl phosphonate modification of the siRNA backbone in the seed region enhances specificity and therapeutic profile.种子区域中siRNA骨架的单烷基膦酸酯修饰可提高特异性和治疗效果。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf692.
3
Targeting CIDEB alleviates liver steatosis and fibrosis in mouse MASH models.靶向CIDEB可减轻小鼠MASH模型中的肝脂肪变性和纤维化。

本文引用的文献

1
Structural basis for microRNA targeting.microRNA 靶向作用的结构基础。
Science. 2014 Oct 31;346(6209):608-13. doi: 10.1126/science.1258040.
2
Transcriptome-wide discovery of microRNA binding sites in human brain.人类大脑中转录组范围内的 microRNA 结合位点的发现。
Neuron. 2014 Jan 22;81(2):294-305. doi: 10.1016/j.neuron.2013.10.062. Epub 2014 Jan 2.
3
RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.具有碱基缺失的 RNA 双链体是亨廷顿和脊髓小脑共济失调 3 表达的有效且等位基因选择性抑制剂。
Mol Ther Nucleic Acids. 2025 May 19;36(2):102567. doi: 10.1016/j.omtn.2025.102567. eCollection 2025 Jun 10.
4
Synthesis of 2'-formamidonucleoside phosphoramidites for suppressing the seed-based off-target effects of siRNAs.2'-甲酰胺核苷亚磷酰胺的合成及其对 siRNA 基于种子的脱靶效应的抑制作用。
Nucleic Acids Res. 2024 Oct 14;52(18):10754-10774. doi: 10.1093/nar/gkae741.
5
Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications.细胞内蛋白质递送:方法、挑战与临床应用
BME Front. 2024 Jan 25;5:0035. doi: 10.34133/bmef.0035. eCollection 2024.
6
Widespread 8-oxoguanine modifications of miRNA seeds differentially regulate redox-dependent cancer development.广泛存在的 miRNA 种子 8-氧鸟嘌呤修饰物差异调控氧化还原依赖型癌症发生。
Nat Cell Biol. 2023 Sep;25(9):1369-1383. doi: 10.1038/s41556-023-01209-6. Epub 2023 Sep 7.
7
Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies.通过细胞穿透肽偶联、化学修饰和基于载体的递送策略提高寡核苷酸疗法的有效性
Pharmaceutics. 2023 Apr 3;15(4):1130. doi: 10.3390/pharmaceutics15041130.
8
Engineering miRNA features into siRNAs: Guide-strand bulges are compatible with gene repression.将微小RNA特征引入小干扰RNA:引导链凸起与基因抑制兼容。
Mol Ther Nucleic Acids. 2022 Feb 10;27:1116-1126. doi: 10.1016/j.omtn.2022.02.004. eCollection 2022 Mar 8.
9
Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs.使用异核苷酸克服 GNA/RNA 碱基配对限制可提高 ESC+GalNAc-siRNAs 的药效活性。
Nucleic Acids Res. 2021 Nov 8;49(19):10851-10867. doi: 10.1093/nar/gkab916.
10
AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity.基于 AGO CLIP 的 SARS-CoV-2 强效 siRNA 序列的推测,具有抗纤维化 miRNA 样活性。
Sci Rep. 2021 Sep 27;11(1):19161. doi: 10.1038/s41598-021-98708-z.
Nucleic Acids Res. 2013 Oct;41(18):8788-801. doi: 10.1093/nar/gkt594. Epub 2013 Jul 24.
4
miRTCat: a comprehensive map of human and mouse microRNA target sites including non-canonical nucleation bulges.miRTCat:人类和小鼠 microRNA 靶位点的综合图谱,包括非经典起始凸起。
Bioinformatics. 2013 Aug 1;29(15):1898-9. doi: 10.1093/bioinformatics/btt296. Epub 2013 May 24.
5
Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding.通过 CLASH 绘制人类 miRNA 相互作用组揭示了频繁的非经典结合。
Cell. 2013 Apr 25;153(3):654-65. doi: 10.1016/j.cell.2013.03.043.
6
MicroRNAs: regulators of neuronal fate.MicroRNAs:神经元命运的调控者。
Curr Opin Cell Biol. 2013 Apr;25(2):215-21. doi: 10.1016/j.ceb.2012.12.007. Epub 2013 Jan 29.
7
The structure of human argonaute-2 in complex with miR-20a.人 Argonaute-2 与 miR-20a 复合物的结构。
Cell. 2012 Jul 6;150(1):100-10. doi: 10.1016/j.cell.2012.05.017. Epub 2012 Jun 7.
8
The crystal structure of human Argonaute2.人源 Argonaute2 的晶体结构
Science. 2012 May 25;336(6084):1037-40. doi: 10.1126/science.1221551. Epub 2012 Apr 26.
9
A 'pivotal' new rule for microRNA-mRNA interactions.一条关于微小RNA与信使RNA相互作用的“关键”新规则。
Nat Struct Mol Biol. 2012 Mar 5;19(3):265-6. doi: 10.1038/nsmb.2256.
10
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.RNA-seq 实验中使用 TopHat 和 Cufflinks 的差异基因和转录本表达分析。
Nat Protoc. 2012 Mar 1;7(3):562-78. doi: 10.1038/nprot.2012.016.